|
 Injectable Division was acquired by the UNIJULES GROUP, it has modern Therapeutics and Bio Pharmaceutical Dept. as a fully equipped Quality control laboratory at that time.
Few years ago Injectable Division was poised to rocket off with firm plans to set up a plant for the manufacturing of inject able (small volume parenterals) and a Research and development cum Public Testing Laboratory.
ln 1995, the company established dedicated parenteral manufacturing facilities in the Hingna industrial area of Nagpur. The promoters of the company are widely respected as a pioneers of pharmaceuticals trade and industry in the Vidharbha region of Central India. The management of the company is headed by technocrats with wide experience in the field of pharmaceutical business.  The state-of-art facility, designed according to the GMP rules, for the manufacturing of injectables, is spread over an area of more than 13,454.88 sq.feet. Amongst the best in Central India, the facilities and equipment are set up for rational production and operations are strictly regulated by standard operating procedure (SOPs). The plant assures compliance through Achievement of WHO-GMP quality system accreditation and with stricy application of cGMP and Quality Systems Requirements. Sourcing if inputs, manufacturing, product specifications and testing are managed to comply with national and international pharmacopoeias for global acceptance.
|
Facilities 
